LCM
CYT

Landscape Capital Management’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Landscape Capital Management’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,080
Closed -$39.8K – 1039
2023
Q4 		$39.8K Buy
+13,080
New +$39.7K ﹤0.01% 784

Other funds holding CYT

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Landscape Capital Management's CYT Position: Q1 2024 in Review

Landscape Capital Management sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q1 2024, closing a stake of 13,080 shares — an estimated $39.8K sold.

Landscape Capital Management first reported a position in CYT in Q4 2023 and held it in 1 quarter. The position peaked at $39.8K in Q4 2023. 4 funds tracked by Wall St. Rank hold CYT as of Q1 2024.

  • Landscape Capital Management reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Landscape Capital Management sold 13,080 Cyteir Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $39.8K.
  • Landscape Capital Management first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Landscape Capital Management's Cyteir Therapeutics, Inc. Common Stock position peaked at $39.8K in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Landscape Capital Management's 13F filing for Q1 2024, filed 9 May 2024.